To put Treasury's new financing projections into context, the Jan-Mar borrowing requirement of $815B would be the largest (nominal $) of any Q1, even though the financing requirement of $520B is not as high as the $656B in Q1 2023. The difference between the two dynamics is due to the large drop in the cash balance in Q1 2023 ($269B), compared with the anticipated cash raise of $128B in that quarter.
Overall the release reflects the fact that there is a new Treasury Secretary and regime in town, and that may also be influencing the relatively benign outlook for borrowing - here's the economic outlook in this quarter's Economy Statement for the Treasury Borrowing Advisory Committee, which notably highlights that the Trump administration looks to reduce deficits:
Find more articles and bullets on these widgets:
Markets slipped on the hawkish Fed and are yet to fully recover, touching 141.65 on the way lower. Medium-term trend signals on the continuation chart continue to point south. A resumption of the trend would pave the way for a move towards 141.56, a Fibonacci projection point on the continuation chart. A stronger recovery would open 144.48, the Nov 11 high. Further out, key resistance is at 146.53, the Aug 6 high (cont).
USDCAD is unchanged and bulls remain in the driver’s seat. The latest pause appears to be a flag formation - a bullish continuation signal. Note too that moving average studies are in a bull-mode position, highlighting a dominant uptrend. Sights are on 1.4508 next, a Fibonacci projection level. Initial firm support to watch lies at 1.4307, the 20-day EMA. A pullback would be considered corrective.
A bearish trend condition in AUDUSD remains intact and the pair continues to trade closer to latest lows. Recent weakness maintains the price sequence of lower lows and lower highs. Note that moving average studies are in a bear-mode position too, highlighting a dominant downtrend. Scope is seen for an extension towards 0.6158 next, a Fibonacci projection. Initial firm resistance to monitor is 0.6282, the 20-day EMA.